From: 26/04/2017 to: 30/04/2017 3rd ESO-ESMO Latin-American Masterclass in Clinical Oncology, San Jose, Costa Rica                                        From: 7/05/2017 to: 7/05/2017 4th ESO Lung Cancer Observatory, Geneva, Switzerland                                        From: 18/05/2017 to: 19/05/2017 Eurasia Course on Gastrointestinal Malignancies, Moscow, Russian Federation                                        From: 22/05/2017 to: 26/05/2017 3rd ESOP-ESO Advanced Masterclass in Oncology Pharmacy, Lisbon, Portugal                                        From: 26/05/2017 to: 27/05/2017 ESMO Preceptorship on Immuno-Oncology 2017, Amsterdam, The Netherlands                                        From: 10/06/2017 to: 13/06/2017 Leukaemia and Lymphoma, Ascona, Switzerland                                        From: 21/06/2017 to: 23/06/2017 Masterclass in Oncology Basics for Beginners, Cambridge, United Kingdom                                        From: 30/06/2017 to: 05/07/2017 4th ESO-ESMO Eastern Europe and Balkan Region Masterclass in Medical Oncology, Belgrade, Serbia                                        From: 13/07/2017 to: 18/07/2017 ESMO-ESO Course on Medical Oncology for Medical Students, Valencia, Spain                                        From: 15/07/2017 to: 15/07/2017 Breast Cancer in Young Women: Joint DFCI-ESO Symposium, Boston, US                                        From: 28/08/2017 to: 08/09/2017 ESO-ESSO-ESTRO Multidisciplinary Course in Oncology for Medical Students, Antwerp, Belgium                                        From: 06/10/2017 to: 07/10/2017 Eastern Europe and Balkan Region Refresher Course on Breast Cancer, Krakow, Poland                                        From: 18/10/2017 to: 20/10/2017 4th Masterclass in Clinical Oncology, Tbilisi, Georgia                                        From: 18/10/2017 to: 18/10/2017 ESO Breast Cancer Observatory, Tehran, Iran                                        From: 27/10/2017 to: 28/10/2017 9th Clinical Oncology Update - Onkologia 2017, Krakow, Poland                                        From: 02/11/2017 to: 04/11/2017 ESO-ESMO Advanced Breast Cancer Fourth International Consensus Conference (ABC4), Lisbon, Portugal                                        From: 02/12/2017 to: 04/12/2017 ESO-ESMO-RCE Clinical Update on Rare Adult Solid Cancers, Milan, Italy                                        From: 15/12/2017 to: 18/12/2017 1st Mediterranean Masterclass in Clinical Oncology, Limassol, Cyprus



It is clear that some radical thinking is required to address access challenges in Europe to ensure that as many patients as possible receive optimal cancer care. This task force examines the issue in greater depth.

Progress to Date
• An initial meeting to discuss the initiative was held in Milan on March 30, 2012
• A small brainstorming meeting was held in Zurich in February 2013
• A multi-stakeholder task force consisting of 26 participants has been confirmed
• First meeting of the entire group was held on October 11/12 in Milan
Article published in Cancer World (Issue 58)
• ESO Workshop: “Access to treatment, definition of innovation and obsolescence in cancer treatments” will be held in
   October 2016 in Luxembourg

Future Plans
• The outcome of the Task Force will be developed further within ECCO with an ECCO position paper published in 2017

The Task Force is chaired by Matti Aapro (CH) and Kathy Redmond (CH).

Members of the task force are: 
Joerg Adamczewski (FR), Nicolai Bodemer (DE), Uday Bose (GB), Johannes Bruns (DE), Agnes Buzyn (FR), Paul Cornes, (GB), Alberto Costa (CH and IT), Pere Gascon (ES), Cai Grau (DK), Birgitte Grube (DK), Bengt Joensson (SE), Finn Borlum Kristensen (DK), Yolande Lievens (BE), Peter Naredi (SE), Kathy Oliver (GB), Roberta Rondena (IT), Pierfrancesco Ruffo (CH), Daniel Schneider (CH), Richard Sullivan (GB), Thomas Szucs (CH), Olli Tenhunen (FI), Giampaolo Tortora (IT).

For further information, please contact:
Alexandra Zampetti

This task force was initiated by Eisai, a sustaining member of the Sharing Progress in Cancer Care (SPCC) programme. SPCC is a pioneering partnership between the European School of Oncology (ESO) and some of the world’s leading pharmaceutical companies.